NCM·Healthcare·$79M·#231 / 520 in Healthcare
FBIO Fortress Biotech, Inc.
48SPECULATIVE
CATEGORY BREAKDOWN
GROWTH15
QUALITY57
STABILITY34
VALUATION99
GOVERNANCE70
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+9.7%
15
> 50% strong
Gross Margin
Revenue retained after direct costs
66.9%
95
> 50% strong
Cash Runway
Months of cash at current burn rate
14 months
50
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
149.0%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.2x
99
< 3x strong
Rule of 40
Growth rate plus operating margin
-101
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
22.8%
89
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+12.4%
33
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE FBIO WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when FBIO's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.